SRXH logo

SRx Health Solutions Inc. (SRXH)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $0.20 ist SRx Health Solutions Inc. (SRXH) ein Healthcare-Unternehmen mit einer Bewertung von 6923564. Bewertet mit 40/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 3. Feb. 2026
40/100 KI-Bewertung MCap 7M Vol 84M

SRx Health Solutions Inc. (SRXH) Gesundheitswesen & Pipeline-Uebersicht

CEOKent Cunningham
Mitarbeiter444
HauptsitzTampa, FL, US
IPO-Jahr2010

SRx Health Solutions delivers comprehensive, integrated specialty healthcare services across Canada, leveraging technology and a patient-centric approach to enhance wellness. With a strong profit margin of 370.9% and a beta of 0.94, SRXH presents a unique opportunity in the Canadian healthcare market.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 3. Feb. 2026

Investmentthese

SRx Health Solutions presents a notable research candidate due to its unique position in the Canadian specialty healthcare market. The company's integrated service model and patient-centric approach drive strong customer loyalty and consistent revenue streams. With a high profit margin of 370.9%, SRx demonstrates efficient operations and strong pricing power. Key growth catalysts include expanding service offerings and penetrating new geographic markets within Canada. The company's beta of 0.94 suggests relatively low volatility compared to the overall market. Investors may want to evaluate SRx for its potential to capitalize on the growing demand for specialized healthcare services in Canada. The company's focus on technology and innovation positions it well for long-term growth and value creation.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Profit Margin of 370.9% indicates strong profitability and efficient cost management.
  • Gross Margin of 12.8% reflects the profitability of SRx's core services.
  • Beta of 0.94 suggests the stock is slightly less volatile than the market.
  • Integrated healthcare services provider operating across all ten Canadian provinces, ensuring broad market coverage.
  • Focus on specialty healthcare services, catering to a growing and specific market segment.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Integrated service model.
  • Patient-centric approach.
  • Strong profit margin (370.9%).
  • Established presence across Canada.

Schwaechen

  • Relatively low gross margin (12.8%).
  • Limited publicly available information.
  • Small market capitalization.

Katalysatoren

  • Upcoming: Expansion into new specialty healthcare areas, increasing service offerings to a broader patient base.
  • Ongoing: Continued integration of technology to improve service delivery and patient outcomes.
  • Ongoing: Strategic partnerships with healthcare providers to expand market reach.

Risiken

  • Potential: Increased competition from larger, more established healthcare providers.
  • Potential: Changes in healthcare regulations impacting service delivery and reimbursement rates.
  • Potential: Economic downturn leading to reduced healthcare spending.
  • Ongoing: Dependence on key personnel and management team.

Wachstumschancen

  • Expansion of Service Offerings: SRx can expand its service offerings to include new specialty areas and innovative healthcare solutions. This would allow the company to attract a wider range of patients and increase revenue streams. The market for specialty healthcare services is growing rapidly, driven by the increasing prevalence of chronic diseases and the aging population. Timeline: Within the next 2-3 years.
  • Geographic Expansion within Canada: SRx can further penetrate existing markets and expand into new geographic areas within Canada. This would allow the company to reach more patients and increase its market share. The Canadian healthcare market is vast, with significant opportunities for growth in underserved areas. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: SRx can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This would allow the company to offer a more comprehensive range of services and strengthen its competitive position. The healthcare industry is consolidating, with many opportunities for strategic alliances. Timeline: Ongoing.
  • Technology Integration and Innovation: SRx can continue to invest in technology and innovation to improve its services and enhance patient outcomes. This would allow the company to differentiate itself from competitors and attract tech-savvy patients. The healthcare industry is rapidly adopting new technologies, such as telehealth and AI-powered diagnostics. Timeline: Ongoing.
  • Focus on Patient Engagement and Education: SRx can enhance its patient engagement and education programs to improve patient adherence and outcomes. This would lead to increased patient satisfaction and loyalty. Engaged and educated patients are more likely to follow treatment plans and achieve better health outcomes. Timeline: Ongoing.

Chancen

  • Expansion of service offerings.
  • Geographic expansion within Canada.
  • Strategic partnerships and acquisitions.

Risiken

  • Competition from larger healthcare providers.
  • Changes in healthcare regulations.
  • Economic downturn affecting healthcare spending.

Wettbewerbsvorteile

  • Integrated service model provides a competitive advantage.
  • Strong relationships with healthcare providers and payers.
  • Focus on patient-centric care fosters loyalty.
  • Established presence across all ten Canadian provinces.

Ueber SRXH

SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company was founded with the vision of providing comprehensive, patient-centric healthcare solutions across Canada. Over the years, SRx has evolved into a key player in the Canadian healthcare landscape, offering customized specialty healthcare services across all ten provinces. SRx combines deep industry knowledge, cutting-edge technology, and a strong patient focus to develop strategies and solutions aimed at improving the health and wellness of Canadians. Their services span a wide range of specialty areas, ensuring that patients receive the specific care they need. SRx differentiates itself through its integrated approach, which allows for seamless coordination of care and improved patient outcomes. The company's commitment to innovation and patient satisfaction has solidified its position as a trusted healthcare partner in Canada. SRx's headquarters are located in Tampa, US, and they employ 444 individuals.

Was das Unternehmen tut

  • Provides integrated healthcare services.
  • Offers customized specialty healthcare solutions.
  • Operates across all ten Canadian provinces.
  • Focuses on improving patient wellness.
  • Combines industry knowledge with technology.
  • Delivers patient-centric care.

Geschaeftsmodell

  • Provides specialty healthcare services to patients across Canada.
  • Generates revenue through service fees and contracts with healthcare providers.
  • Focuses on integrated and customized solutions to improve patient outcomes.

Branchenkontext

SRx Health Solutions operates in the Canadian healthcare industry, which is characterized by increasing demand for specialized services and a growing aging population. The market is competitive, with players like AEON, BOLT, CLRB, GELS, and MRKR vying for market share. SRx differentiates itself through its integrated approach and patient-centric focus. The Canadian healthcare market is expected to continue growing, driven by factors such as technological advancements and increasing healthcare expenditure. SRx is well-positioned to capitalize on these trends, leveraging its expertise and established presence in the market.

Wichtige Kunden

  • Patients requiring specialized healthcare services.
  • Healthcare providers seeking integrated solutions.
  • Insurance companies and other payers.
KI-Zuversicht: 71% Aktualisiert: 3. Feb. 2026

Finanzdaten

Chart & Info

SRx Health Solutions Inc. (SRXH) Aktienkurs: $0.20 (-0.03, -14.50%)

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer SRXH.

Kursziele

Wall-Street-Kurszielanalyse fuer SRXH.

MoonshotScore

40/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von SRXH auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

SRx Health Solutions Inc. Aktie: Wichtige Fragen beantwortet

What are the key factors to evaluate for SRXH?

SRx Health Solutions Inc. (SRXH) currently holds an AI score of 40/100, indicating low score. Key strength: Integrated service model.. Primary risk to monitor: Potential: Increased competition from larger, more established healthcare providers.. This is not financial advice.

How frequently does SRXH data refresh on this page?

SRXH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven SRXH's recent stock price performance?

Recent price movement in SRx Health Solutions Inc. (SRXH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Integrated service model.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider SRXH overvalued or undervalued right now?

Determining whether SRx Health Solutions Inc. (SRXH) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying SRXH?

Before investing in SRx Health Solutions Inc. (SRXH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding SRXH to a portfolio?

Potential reasons to consider SRx Health Solutions Inc. (SRXH) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Integrated service model.. Additionally: Patient-centric approach.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of SRXH?

Yes, most major brokerages offer fractional shares of SRx Health Solutions Inc. (SRXH) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track SRXH's earnings and financial reports?

SRx Health Solutions Inc. (SRXH) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for SRXH earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Financial data is based on limited publicly available information.
  • Analysis is based on current market conditions and may be subject to change.
Datenquellen

Popular Stocks